Evidence map›Paper›PMID 25407514›Full record

ArticleRetrovirology2014

Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation.

Donglai Liu, Tao Zuo, Bhavna Hora, Hongshuo Song, Wei Kong, Xianghui Yu, Nilu Goonetilleke, Tanmoy Bhattacharya, Alan S Perelson, Barton F Haynes and 2 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Role of HLA Adaptation in HIV Evolution.Frontiers in immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Donglai LiuDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. ldl198653@126.com.
Tao ZuoDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. ootaoz@aliyun.com.
Bhavna HoraDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. bhavna.hora@dm.duke.edu.
Hongshuo SongDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. hongshuo.song@dm.duke.edu.
Wei KongNational Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. weikong@mail.jlu.edu.cn.
Xianghui YuNational Engineering Laboratory For AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, Jilin, China. xianghui@jlu.edu.cn.
Nilu GoonetillekeDepartment of Microbiology, Immunology and Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. nilu_goonetilleke@med.unc.edu.
Tanmoy BhattacharyaTheoretical Division, Los Alamos National laboratory, Los Alamos, NM, 87545, USA. tanmoy@lanl.gov.
Alan S PerelsonTheoretical Division, Los Alamos National laboratory, Los Alamos, NM, 87545, USA. asp@lanl.gov.
Barton F HaynesDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. barton.haynes@dm.duke.edu.
Andrew J McMichaelWeatherall Institute of molecular Medicine, University of Oxford, Oxford, OX3 9DS, England, UK. andrew.mcmichael@ndm.ox.ac.uk.
Feng GaoDuke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA. fgao@duke.edu.
Duke Medical Center · USJilin Medical University · CNJilin University · CNLos Alamos National Laboratory · USUniversity of North Carolina at Chapel Hill · USUniversity of Oxford · GB

Funding

Viral Sequencing CoreU19AI067854 · NIAID · DUKE UNIVERSITY · PI LETVIN, NORMAN L · 2006 to 2011
$290.5M
Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI MCMICHAEL, ANDREW JAMES · 2012 to 2018
$204.7M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
Immune System Modeling/HIVR37AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 2002 to 2011
$2.4M
NIAID NIH HHS AI028433NIAID NIH HHS AI067854NIAID NIH HHS AI100645NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI028433NIAID NIH HHS R37 AI028433NIAID NIH HHS U01 AI067854NIAID NIH HHS U19 AI067854NIAID NIH HHS UM1 AI100645NIH HHS R01 OD011095
6 · The paper itself

Abstract

backgroundFitness costs and slower disease progression are associated with a cytolytic T lymphocyte (CTL) escape mutation T242N in Gag in HIV-1-infected individuals carrying HLA-B*57/5801 alleles. However, the impact of different context in diverse HIV-1 strains on the fitness costs due to the T242N mutation has not been well characterized. To better understand the extent of fitness costs of the T242N mutation and the repair of fitness loss through compensatory amino acids, we investigated its fitness impact in different transmitted/founder (T/F) viruses.

resultsThe T242N mutation resulted in various levels of fitness loss in four different T/F viruses. However, the fitness costs were significantly compromised by preexisting compensatory amino acids in (Isoleucine at position 247) or outside (glutamine at position 219) the CTL epitope. Moreover, the transmitted T242N escape mutant in subject CH131 was as fit as the revertant N242T mutant and the elimination of the compensatory amino acid I247 in the T/F viral genome resulted in significant fitness cost, suggesting the fitness loss caused by the T242N mutation had been fully repaired in the donor at transmission. Analysis of the global circulating HIV-1 sequences in the Los Alamos HIV Sequence Database showed a high prevalence of compensatory amino acids for the T242N mutation and other T cell escape mutations.

conclusionsOur results show that the preexisting compensatory amino acids in the majority of circulating HIV-1 strains could significantly compromise the fitness loss due to CTL escape mutations and thus increase challenges for T cell based vaccines.

Indexed as

Immune EvasionMutation, MissenseVirus ReplicationAmino Acidsgag Gene Products, Human Immunodeficiency VirusHIV-1HumansT-LymphocytesAmino Acidsgag Gene Products, Human Immunodeficiency Virus

Identifiers

PMID25407514
PMCPMC4264250
OpenAlexW2132790240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.